Court Restricts Samsung Biologics Strike Across Nine Production Processes

The Incheon branch of the Seoul High Court expanded an injunction against the Samsung Biologics union strike from three to nine production processes, requiring normal staffing and operations. Each violation carries a 20 million won (~$15,502) penalty. The union is reviewing its planned three-week second strike set for Oct. 26.

• Court expanded restrictions from 3 to 9 processes, including cell culture and virus filtration
• Penalty for violations set at 20 million won (~$15,502) per case
• Union demands a 15.5% wage increase for entry-level employees
• The May strike cost an estimated 150 billion won in lost revenue